Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVSEF) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Novartis Ag (NVSEF) over the last 17 years, with Q4 2025 value amounting to $4.5 billion.

  • Novartis Ag's Accounts Payables fell 253.72% to $4.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $4.5 billion, marking a year-over-year decrease of 253.72%. This contributed to the annual value of $4.5 billion for FY2025, which is 253.72% down from last year.
  • Novartis Ag's Accounts Payables amounted to $4.5 billion in Q4 2025, which was down 253.72% from $4.6 billion recorded in Q3 2025.
  • Novartis Ag's Accounts Payables' 5-year high stood at $5.6 billion during Q4 2021, with a 5-year trough of $3.9 billion in Q3 2023.
  • In the last 5 years, Novartis Ag's Accounts Payables had a median value of $4.7 billion in 2021 and averaged $4.7 billion.
  • In the last 5 years, Novartis Ag's Accounts Payables crashed by 2513.82% in 2024 and then skyrocketed by 1145.09% in 2025.
  • Novartis Ag's Accounts Payables (Quarter) stood at $5.6 billion in 2021, then dropped by 7.33% to $5.1 billion in 2022, then dropped by 4.28% to $4.9 billion in 2023, then decreased by 7.19% to $4.6 billion in 2024, then dropped by 2.54% to $4.5 billion in 2025.
  • Its Accounts Payables was $4.5 billion in Q4 2025, compared to $4.6 billion in Q3 2025 and $4.5 billion in Q2 2025.